Insiders · IONS

Eugene Schneider

EVP, Chf Clinical Develop Ofcr at Ionis Pharmaceuticals Inc (IONS) since December 2020

Eugene Schneider has filed 27 insider reports with the SEC since January 2021, as EVP and chf Clinical Develop Ofcr at Ionis Pharmaceuticals Inc (IONS). In the last 12 months Eugene Schneider sold $3.74M of stock on the open market. In the latest filing, on June 30, 2026, Eugene Schneider sold 26,000 shares of Ionis Pharmaceuticals Inc (IONS) for $2.11M at an average of $81.05.

Filings
27
Companies
1
Bought on market
None
Sold on market
$8.05M

Companies where Eugene Schneider is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Ionis Pharmaceuticals Inc logo
IONS
Ionis Pharmaceuticals Inc
EVP, Chf Clinical Develop Ofcrsince December 202077,114$8.05M$26.58Jun 30, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Eugene Schneider with

Other insiders at the same companies

Questions about Eugene Schneider

What is Eugene Schneider's role at Ionis Pharmaceuticals Inc?
Eugene Schneider reports to the SEC as EVP and chf Clinical Develop Ofcr at Ionis Pharmaceuticals Inc (IONS), according to the latest filing on June 30, 2026.
How many shares does Eugene Schneider own?
After the latest filing that states it, Eugene Schneider directly owned 77,114 shares of Ionis Pharmaceuticals Inc (IONS). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Eugene Schneider bought or sold stock recently?
The most recent open-market sale was on June 26, 2026: sold 26,000 shares of Ionis Pharmaceuticals Inc (IONS) for $2.11M at an average of $81.05.
How do I get alerts when Eugene Schneider files?
Follow Eugene Schneider on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Eugene Schneider (SEC CIK 0001838539). Totals count each trade once, skipping amendments whose original is on file, from Jan 20, 2021 on. View on SEC EDGAR · Get this as JSON